News

XL-protein GmbH and Easton Pharmaceutical Co., Ltd. announced that they have entered into a License, Development and Commercialization Agreement for novel, long-acting biopharmaceutical…
Read More...

PAREXEL International Corporation introduced IMPACT Express Clinical Trial Management System (CTMS). IMPACT Express provides a quick-to-implement, cost-effective clinical trial…
Read More...

Biovica’s DiviTum technology has been selected by the International Breast Cancer Study Group (IBCSG, Bern) and the Breast International Group (BIG, Brussels) to be part of a state of…
Read More...

Siemens Healthcare has announced that the U.S. Food and Drug Administration (FDA) has cleared the Multitom Rax (Robotic Advanced X-ray), a universal diagnostic imaging system that…
Read More...

Crown Bioscience is offering an immuno-oncology translational research platform. Crown Bioscience president Jean-Pierre Wery said: "Crown's suite of in vitro and in vivo…
Read More...

PAREXEL International Corporation announced the enhancement of its end-to-end clinical development services through its new process, called Clinical Development Optimization.  The…
Read More...

Meridian Bioscience has made a minority investment in Oasis Diagnostics ("Oasis"), with the right to acquire Oasis in the future. The terms of the transaction were not disclosed.…
Read More...

Essential Pharmaceuticals, LLC announces the release of Cell-Ess media supplement for cell culture and large scale bioproduction of proteins and vaccines.  This novel supplement can be…
Read More...

Merck known as MSD outside the United States and Canada, and DNAtrix announced they have entered into an oncology clinical study collaboration to evaluate the efficacy and safety of…
Read More...